vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Legacy Education Inc. (LGCY). Click either name above to swap in a different company.
Legacy Education Inc. is the larger business by last-quarter revenue ($19.2M vs $13.8M, roughly 1.4× FENNEC PHARMACEUTICALS INC.). Legacy Education Inc. runs the higher net margin — 10.6% vs -34.7%, a 45.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 40.7%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.
FENC vs LGCY — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $19.2M |
| Net Profit | $-4.8M | $2.0M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 13.3% |
| Net Margin | -34.7% | 10.6% |
| Revenue YoY | 73.8% | 40.7% |
| Net Profit YoY | -141.1% | 46.0% |
| EPS (diluted) | $-0.17 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $19.2M | ||
| Q3 25 | $12.5M | $19.4M | ||
| Q2 25 | $9.7M | $18.0M | ||
| Q1 25 | $8.8M | $18.6M | ||
| Q4 24 | $7.9M | $13.6M | ||
| Q3 24 | $7.0M | $14.0M | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $25.4M | — |
| Q4 25 | $-4.8M | $2.0M | ||
| Q3 25 | $-638.0K | $2.2M | ||
| Q2 25 | $-3.2M | $1.2M | ||
| Q1 25 | $-1.2M | $2.8M | ||
| Q4 24 | $-2.0M | $1.4M | ||
| Q3 24 | $-5.7M | $2.1M | ||
| Q2 24 | $-5.6M | — | ||
| Q1 24 | $12.8M | — |
| Q4 25 | -18.5% | 13.3% | ||
| Q3 25 | -1.5% | 13.9% | ||
| Q2 25 | -28.3% | 11.1% | ||
| Q1 25 | -9.2% | 19.7% | ||
| Q4 24 | -11.8% | 12.2% | ||
| Q3 24 | -74.6% | 19.1% | ||
| Q2 24 | -69.4% | — | ||
| Q1 24 | 54.2% | — |
| Q4 25 | -34.7% | 10.6% | ||
| Q3 25 | -5.1% | 11.3% | ||
| Q2 25 | -32.7% | 6.8% | ||
| Q1 25 | -13.3% | 15.2% | ||
| Q4 24 | -25.0% | 10.3% | ||
| Q3 24 | -82.2% | 14.9% | ||
| Q2 24 | -76.5% | — | ||
| Q1 24 | 50.6% | — |
| Q4 25 | $-0.17 | $0.15 | ||
| Q3 25 | $-0.02 | $0.16 | ||
| Q2 25 | $-0.11 | $0.07 | ||
| Q1 25 | $-0.04 | $0.21 | ||
| Q4 24 | $-0.02 | $0.10 | ||
| Q3 24 | $-0.21 | $0.21 | ||
| Q2 24 | $-0.20 | — | ||
| Q1 24 | $0.41 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $21.1M |
| Total DebtLower is stronger | — | $660.3K |
| Stockholders' EquityBook value | $35.5M | $46.1M |
| Total Assets | $70.6M | $73.1M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $21.1M | ||
| Q3 25 | $21.9M | $20.6M | ||
| Q2 25 | $18.7M | $20.3M | ||
| Q1 25 | $22.7M | $17.3M | ||
| Q4 24 | $26.6M | $16.9M | ||
| Q3 24 | $40.3M | $21.5M | ||
| Q2 24 | $43.1M | — | ||
| Q1 24 | $51.2M | — |
| Q4 25 | — | $660.3K | ||
| Q3 25 | $19.4M | $776.9K | ||
| Q2 25 | $19.4M | $1.4M | ||
| Q1 25 | $19.4M | $1.0M | ||
| Q4 24 | $19.3M | $1.1M | ||
| Q3 24 | $32.1M | $758.2K | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $46.1M | ||
| Q3 25 | $-4.5M | $43.7M | ||
| Q2 25 | $-7.5M | $41.0M | ||
| Q1 25 | $-5.9M | $39.3M | ||
| Q4 24 | $-5.9M | $36.4M | ||
| Q3 24 | $-5.2M | $32.6M | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | $70.6M | $73.1M | ||
| Q3 25 | $49.3M | $72.1M | ||
| Q2 25 | $44.9M | $69.2M | ||
| Q1 25 | $46.4M | $67.1M | ||
| Q4 24 | $44.9M | $62.1M | ||
| Q3 24 | $58.9M | $50.6M | ||
| Q2 24 | $63.2M | — | ||
| Q1 24 | $69.2M | — |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $1.1M |
| Free Cash FlowOCF − Capex | — | $512.7K |
| FCF MarginFCF / Revenue | — | 2.7% |
| Capex IntensityCapex / Revenue | — | 2.8% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $1.1M | ||
| Q3 25 | $1.5M | $1.1M | ||
| Q2 25 | $-3.7M | $3.0M | ||
| Q1 25 | $-4.3M | $918.7K | ||
| Q4 24 | $-1.5M | $659.0K | ||
| Q3 24 | $-2.2M | $3.2M | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $39.0M | — |
| Q4 25 | — | $512.7K | ||
| Q3 25 | — | $809.7K | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $596.6K | ||
| Q4 24 | — | $466.8K | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 16.2% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 21.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.8% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 2.45× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
